TABLE 2

Dysregulated proteins involved in competitive growth advantage

GI no., descriptionaProtein abundance ratiobCOG categoryc
UV-SpaceUV-MarsDark-SpaceDark-Mars
500857672, nonribosomal peptide synthetase*0.7300.8401.1570.920SMB
500857673, polyketide synthase0.7900.8130.6270.812SMB
500857674, polyketide synthase0.8790.7390.5570.793SMB
500857675, polyketide synthase0.9580.7640.4720.825SMB
500859561, chemotaxis protein−0.2780.1100.655−0.085CM
500859564, chemotaxis protein0.2320.5121.0990.424CM
500858269, chemotaxis protein CheV−0.1230.0070.681−0.116CM
500858470, chemotaxis protein CheW−0.0510.1500.7760.076CM
500858471, chemotaxis protein CheC0.0460.3270.8780.054STM
500860007, methyl-accepting chemotaxis protein0.1280.3920.7300.221CM
500859562, methyl-accepting chemotaxis protein−0.0620.1111.0240.202CM
500858139, flagellin0.1400.2630.6540.499CM
500858460, flagellar basal body-associated protein FliL−0.452−0.5291.081−0.437CM
500858457, flagellar hook assembly protein FlgD−0.684−0.8460.520−0.669CM
500858451, flagellar motor switch protein FliG−0.0930.1600.614−0.091CM
  • a *, P ≤ 0.05 (one-way ANOVA).

  • b The values shown represent protein abundance ratios (log2) normalized to the ground control.

  • c SMB, secondary metabolite biosynthesis, transport and catabolism; CM, cell motility; STM, signal transduction mechanisms.